Induction of type I IFNs by intracellular DNA‐sensing pathways

Immunology and Cell Biology - Tập 90 Số 5 - Trang 474-482 - 2012
Taner Cavlar1, Andrea Ablasser1, Veit Hornung1
1Institute for Clinical Chemistry and Clinical Pharmacology, Unit for Clinical Biochemistry, University Hospital, University of Bonn, Bonn, Germany

Tóm tắt

A successful antimicrobial immune response involves the coordinate action of cells and soluble factors, with the cytokine family of type I interferons (IFNs) having a central role. Type I IFNs are not only crucial in conferring immediate antimicrobial, most importantly antiviral effects, but they also have an essential role in bridging the innate with the adaptive immune response. Therefore, production of these key cytokines must be tightly controlled. To this effect the host has evolved a set of pattern recognition receptors (PRRs) that reliably and specifically detect the presence of microbial pathogens before mounting an IFN response. Most PRR pathways that are known to induce type I IFNs are triggered upon recognition of nucleic acids. This mode of sensing is not straightforward, as large amounts of RNA and DNA are also present within the host. Nevertheless, in some cases distinct molecular features that are present within foreign nucleic acids but absent in endogenous nucleic acids, allow the host to reliably discriminate between ‘self’ and ‘non‐self’. At the same time, compartmentalization of PRRs within subcellular organelles that are usually devoid of host nucleic acids, but are sites of pathogen localization, is another principle that enables the host to distinguish self from non‐self. The latter mode of sensing applies to the detection of microbial DNA within the cytoplasm, a compartment in which host DNAs are usually not present. Despite the past years’ tremendous progress in the field of innate immunity, our understanding of cytoplasmic DNA sensing mechanisms is only beginning to form/take form. In this review, we outline the recent advancements in the elucidation of intracellular DNA‐sensing pathways and discuss the future directions of this emerging field.

Từ khóa


Tài liệu tham khảo

10.1038/ni.1863

10.1111/j.1600-065X.2011.01052.x

10.1098/rspb.1957.0048

10.1016/S0140-6736(63)92585-6

10.1038/197564a0

10.1073/pnas.58.3.1004

Tokunaga T, 1984, Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity, J Natl Cancer Inst, 72, 955

10.1038/374546a0

10.1038/35047123

Fox BA, 1998, Lipofection indirectly increases expression of endogenous major histocompatibility complex class I molecules on tumor cells, Cancer Gene Ther, 5, 307

10.1016/S0014-5793(98)01097-7

10.1073/pnas.96.5.2285

10.1084/jem.20051654

10.1038/ni1146

10.1016/j.ymthe.2004.09.008

10.4049/jimmunol.174.10.6129

10.1038/ni1282

10.1016/j.immuni.2005.12.003

10.1038/nature06013

10.1073/pnas.0801295105

10.1038/nature06537

10.1038/embor.2009.109

10.1038/ni1087

10.4049/jimmunol.175.8.5260

10.4049/jimmunol.175.5.2851

10.1126/science.1132505

10.1126/science.1132998

10.1016/j.immuni.2009.05.008

10.1038/mt.2010.90

10.1038/nature04734

10.1128/JVI.00770-09

10.1128/JVI.01106-10

10.1016/j.immuni.2006.04.004

10.1038/ni1243

10.1016/j.cell.2010.04.018

10.1073/pnas.0703285104

10.1038/ni.1779

10.1016/j.cell.2009.06.015

10.4161/rna.7.2.11058

10.1371/journal.ppat.1000665

10.1038/nature07317

10.1016/j.immuni.2008.09.003

10.1073/pnas.0900850106

10.1128/MCB.00640-08

10.1038/nature08476

10.1016/j.immuni.2011.05.016

10.1128/IAI.00999-10

10.1016/j.cell.2011.09.022

10.1126/science.1189801

10.1038/nature10429

10.1038/nature07725

10.1038/nature07710

10.1126/science.1169841

10.1038/ni.1702

10.1038/ni.1932

10.1371/journal.pone.0027040

10.1016/j.chom.2011.04.008

10.1093/nar/26.15.3460

10.1038/ni.1876

10.1093/nar/gkl652

10.1038/nrm2654

10.1016/j.sbi.2010.03.011

10.1073/pnas.1006539107

10.1146/annurev.immunol.20.100301.064842

10.1093/nar/gkl460

10.1073/pnas.0403555101

10.4049/jimmunol.179.9.6176

10.1016/j.immuni.2011.03.027

10.4049/jimmunol.1101307

10.1038/ni.2091

10.4049/jimmunol.1003389

10.1016/S0092-8674(00)00194-X

10.1111/j.1365-2567.2006.02367.x

10.1177/0961203308090020

10.1038/icb.2012.10

10.1016/j.jaut.2009.10.001

10.1038/ng2091

10.1016/j.cell.2007.10.017

10.1016/j.cell.2008.06.032

10.1038/ni.1941